Ligand Reports Fourth Quarter and Full Year 2016 Financial Results

Go back to Ligand Reports Fourth Quarter and Full Year 2016 Financial Results
LIGAND PHARMA (NASDAQ: LGND) Delayed: 292.81 +2.74 (0.94%)
Previous Close $290.07    52 Week High $139.79 
Open $291.00    52 Week Low $82.07 
Day High $292.85    P/E 680.95 
Day Low $289.00    EPS $0.43 
Volume 43,729